Evidence map›Paper›PMID 24535726›Full record

ArticleGenetic epidemiology2014

A system-level pathway-phenotype association analysis using synthetic feature random forest.

Qinxin Pan, Ting Hu, James D Malley, Angeline S Andrew, Margaret R Karagas, Jason H Moore

Abstract read
In one paragraph

Article in Genetic epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Distinct medical and substance use histories associate with cognitive decline in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Heterogeneous network approaches to protein pathway prediction.Computational and structural biotechnology journal · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gene set analysis: A step-by-step guide.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2015
    Review
  8. Review
  9. Review
  10. Article
  11. Synthetic learning machines.BioData mining · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qinxin PanDepartment of Genetics, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, United States of America.
Ting Hu
James D Malley
Angeline S Andrew
Margaret R Karagas
Jason H Moore
Dartmouth College · USNational Institutes of Health · US

Funding

VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI BORSUK, MARK EDWARD · 1995 to 2019
$52.0M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
Bioinformatics Strategies for Genome-Wide Association StudiesR01LM010098 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., WILLIAMS, SCOTT MATTHEW · 2009 to 2023
$5.1M
Bioinformatics Strategies: Biodefense Vaccine ResearchR01AI059694 · NIAID · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2004 to 2012
$4.5M
Machine Learning Prediction of Cancer SusceptibilityR01LM009012 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H. · 2006 to 2014
$3.3M
QUANTITATIVE BIOLOGY RESEARCH INSTITUTEP20RR024475 · NCRR · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2011 to 2011
$2.3M
Statistical Learning for Biomedical DataZIACT000271 · CIT · CENTER FOR INFORMATION TECHNOLOGY · PI MALLEY, JAMES D · 2009 to 2017
$1.2M
Bladder Cancer Prognostic IndicatorsK07CA102327 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2005 to 2009
$819k
MicroRNA dysregulation and bladder cancer prognosisR21CA182659 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2014 to 2015
$388k
Comprehensive Assessment of Bladder Cancer Genetic SusceptibilityR03CA121382 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2006 to 2007
$158k
NCI NIH HHS K07 CA102327NCI NIH HHS R01 CA057494NCI NIH HHS R01-CA5749367NCI NIH HHS R03 CA121382NCI NIH HHS R21 CA182659NCRR NIH HHS P20 RR024475NIAID NIH HHS R01 AI059694NIAID NIH HHS R01-AI59694NIEHS NIH HHS P42 ES007373NIEHS NIH HHS P42-ES007373NIGMS NIH HHS P20 GM103534NIGMS NIH HHS P20-GM103534NLM NIH HHS R01 LM009012NLM NIH HHS R01-LM009012NLM NIH HHS R01 LM010098NLM NIH HHS R01-LM010098
6 · The paper itself

Abstract

As the cost of genome-wide genotyping decreases, the number of genome-wide association studies (GWAS) has increased considerably. However, the transition from GWAS findings to the underlying biology of various phenotypes remains challenging. As a result, due to its system-level interpretability, pathway analysis has become a popular tool for gaining insights on the underlying biology from high-throughput genetic association data. In pathway analyses, gene sets representing particular biological processes are tested for significant associations with a given phenotype. Most existing pathway analysis approaches rely on single-marker statistics and assume that pathways are independent of each other. As biological systems are driven by complex biomolecular interactions, embracing the complex relationships between single-nucleotide polymorphisms (SNPs) and pathways needs to be addressed. To incorporate the complexity of gene-gene interactions and pathway-pathway relationships, we propose a system-level pathway analysis approach, synthetic feature random forest (SF-RF), which is designed to detect pathway-phenotype associations without making assumptions about the relationships among SNPs or pathways. In our approach, the genotypes of SNPs in a particular pathway are aggregated into a synthetic feature representing that pathway via Random Forest (RF). Multiple synthetic features are analyzed using RF simultaneously and the significance of a synthetic feature indicates the significance of the corresponding pathway. We further complement SF-RF with pathway-based Statistical Epistasis Network (SEN) analysis that evaluates interactions among pathways. By investigating the pathway SEN, we hope to gain additional insights into the genetic mechanisms contributing to the pathway-phenotype association. We apply SF-RF to a population-based genetic study of bladder cancer and further investigate the mechanisms that help explain the pathway-phenotype associations using SEN. The bladder cancer associated pathways we found are both consistent with existing biological knowledge and reveal novel and plausible hypotheses for future biological validations.

Indexed as

Models, GeneticPhenotypeEpistasis, GeneticGenome-Wide Association StudyGenotypeHumansLogistic ModelsPolymorphism, Single NucleotideReproducibility of ResultsUrinary Bladder Neoplasmsepistasisinteractionspathway analysisstatistical epistasis network (SEN)synthetic feature random forest (SF-RF)

Identifiers

PMID24535726
PMCPMC4327826
OpenAlexW2134946690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.